Oropharyngeal Tumor Induction Chemotherapy and Response-stratified Locoregional Therapy Trial in Order to Minimize Long-term Adverse Events

Conditions:   HPV-Related Squamous Cell Carcinoma;   HNSCC
Interventions:   Drug: nab-paclitaxel;   Drug: Carboplatin;   Drug: Nivolumab;   Drug: Cisplatin;   Drug: Hydroxyurea;   Drug: 5-FU;   Drug: Dexamethasone;   Drug: Famotidine;   Drug: Diphenhydramine;   Drug: Paclitaxel;   Procedure: Transoral robotic surgery (TORS);   Radiation: Adjuvant RT;   Radiation: Chemoradiotherapy
Sponsor:   University of Chicago
Not yet recruiting - verified April 2017

http://ift.tt/2oUG5Hw